Skip to main content

Lamivudine

NDC 65862-025 · Aurobindo Pharma Limited

Generic nameLamivudine
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)LAMIVUDINE
Strength150 mg/1
Pharmacologic classHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]
Marketing categoryANDA

Packages

65862-025-10 — 6 BLISTER PACK in 1 CARTON (65862-025-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK

65862-025-60 — 60 TABLET, FILM COATED in 1 BOTTLE (65862-025-60)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

57237-274 — Lamivudine, 60429-353 — lamivudine, 60429-354 — lamivudine, 60505-3250 — Lamivudine, 60505-3251 — lamivudine, 60505-3252 — lamivudine, 60687-720 — Lamivudine, 62135-706 — lamivudine oral, 64380-710 — Lamivudine, 64380-711 — Lamivudine, 65862-026 — Lamivudine, 65862-036 — Lamivudine and Zidovudine, 65862-055 — Lamivudine, 65862-335 — Abacavir and Lamivudine, 67046-1459 — Lamivudine, 68180-286 — ABACAVIR , LAMIVUDINE AND ZIDOVUDINE, 68180-288 — Abacavir and Lamivudine, 68180-602 — Lamivudine, 68999-706 — lamivudine oral, 69097-362 — Abacavir and lamivudine, +32 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.